Segundo, Marjune, MR. F.
HRN: 01-00-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2025
CEFUROXIME 750MG (VIAL)
02/14/2025
02/21/2025
IV
750
Q8hours
MILD TBI SEC TO MVA
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes